Vaxxa AB (NGM:VAXXA)
Sweden · Delayed Price · Currency is SEK 0.4930
-0.0050 (-1.00%)
At close: Jul 30, 2026
Vaxxa AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 92.78 | 77.45 | 84.19 | 53.58 | - | 4.75 | |
Revenue Growth | 26.16% | -8.01% | 57.14% | - | - | 690.54% |
Cost of Revenue | 90.85 | 76.04 | 77.57 | 53.46 | 0.54 | 4.8 |
Gross Profit | 1.93 | 1.41 | 6.63 | 0.12 | -0.54 | -0.05 |
Selling, General & Admin | 9.02 | 8.67 | 4.86 | 5.25 | 1.78 | 5.6 |
Other Operating Expenses | -0.61 | -0.17 | -0.59 | -2.06 | 0.03 | -0.37 |
Operating Expenses | 10.64 | 10.8 | 6.33 | 4.44 | 1.81 | 7.86 |
Operating Income | -8.71 | -9.38 | 0.3 | -4.32 | -2.35 | -7.91 |
Interest Expense | -0.05 | -0.05 | -0.15 | -0.66 | -0.24 | -4.67 |
Interest & Investment Income | - | 0.08 | 0.24 | 0.02 | - | 0.03 |
Earnings From Equity Investments | - | - | - | - | -38.94 | - |
Other Non Operating Income (Expenses) | - | - | - | -0.14 | -0.4 | - |
Pretax Income | -8.77 | -9.35 | 0.39 | -5.1 | -41.93 | -12.55 |
Income Tax Expense | - | - | - | - | - | 0.28 |
Net Income | -8.77 | -9.35 | 0.39 | -5.1 | -41.93 | -12.83 |
Net Income to Common | -8.77 | -9.35 | 0.39 | -5.1 | -41.93 | -12.83 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 43 | 43 | 39 | 25 | 2 | 1 |
Shares Outstanding (Diluted) | 43 | 43 | 39 | 25 | 2 | 1 |
Shares Change | -2.50% | 11.34% | 52.28% | 1295.73% | 191.14% | 86.97% |
EPS (Basic) | -0.20 | -0.22 | 0.01 | -0.20 | -22.97 | -20.46 |
EPS (Diluted) | -0.20 | -0.22 | 0.01 | -0.20 | -22.97 | -20.46 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | - | - | - | -2.29 | -6.82 |
Free Cash Flow Per Share | - | - | - | - | -1.25 | -10.88 |
Gross Margin | 2.08% | 1.82% | 7.87% | 0.23% | - | -1.14% |
Operating Margin | -9.39% | -12.12% | 0.36% | -8.06% | - | -166.68% |
Profit Margin | -9.45% | -12.08% | 0.46% | -9.51% | - | -270.27% |
Free Cash Flow Margin | - | - | - | - | - | -143.64% |
EBITDA | -6.48 | -7.09 | 2.35 | -1.82 | 8.4 | -5.29 |
EBITDA Margin | -6.98% | -9.15% | 2.79% | -3.40% | - | -111.45% |
D&A For EBITDA | 2.24 | 2.29 | 2.05 | 2.5 | 10.75 | 2.62 |
EBIT | -8.71 | -9.38 | 0.3 | -4.32 | -2.35 | -7.91 |
EBIT Margin | -9.39% | -12.12% | 0.36% | -8.06% | - | -166.68% |
Revenue as Reported | 93.4 | 77.62 | 84.78 | 55.64 | -0.03 | 5.11 |